MedTrace Logo

ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study

NCT01377402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 982

Last updated 2017-05-02

Study results available
· View outcomes & findings →

Summary

The first aim of this trial is to assess the long-term prognostic value of Omega-3 index, which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane, in an unselected, regional multicenter observational study of 982 chest pain patients admitted to the emergency unit, employing blood samples collected at admission.

The second purpose of this study is to evaluate the prognostic utility of vitamin D in the same population.

The third purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).

Conditions

Sponsors & Collaborators

  • Universidad Católica de Salta

    collaborator UNKNOWN

  • Helse Stavanger HF

    lead OTHER_GOV

Principal Investigators

  • Dennis WT Nilsen, MD PhD Prof. · Helse Stavanger HF

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Argentina
  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01377402 on ClinicalTrials.gov